Literature DB >> 19616617

Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease.

Tuan Hoang1, Dong-Kug Choi, Makiko Nagai, Du-Chu Wu, Tetsuya Nagata, Delphine Prou, Glenn L Wilson, Miquel Vila, Vernice Jackson-Lewis, Valina L Dawson, Ted M Dawson, Marie-Françoise Chesselet, Serge Przedborski.   

Abstract

DNA damage is a proposed pathogenic factor in neurodegenerative disorders such as Parkinson disease. To probe the underpinning mechanism of such neuronal perturbation, we sought to produce an experimental model of DNA damage. We thus first assessed DNA damage by in situ nick translation and emulsion autoradiography in the mouse brain after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 4 x 20 mg/kg, ip, every 2 h), a neurotoxin known to produce a model of Parkinson disease. Here we show that DNA strand breaks occur in vivo in this mouse model of Parkinson disease with kinetics and a topography that parallel the degeneration of substantia nigra neurons, as assessed by FluoroJade labeling. Previously, nitric oxide synthase and cyclooxygenase-2 (Cox-2) were found to modulate MPTP-induced dopaminergic neuronal death. We thus assessed the contribution of these enzymes to DNA damage in mice lacking neuronal nitric oxide synthase (nNOS), inducible nitric oxide synthase (iNOS), or Cox-2. We found that the lack of Cox-2 and nNOS activities but not of iNOS activity attenuated MPTP-related DNA damage. We also found that not only nuclear, but also mitochondrial, DNA is a target for the MPTP insult. These results suggest that the loss of genomic integrity can be triggered by the concerted actions of nNOS and Cox-2 and provide further support to the view that DNA damage may contribute to the neurodegenerative process in Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616617      PMCID: PMC3690578          DOI: 10.1016/j.freeradbiomed.2009.07.013

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  38 in total

1.  Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice.

Authors:  E Bezard; S Dovero; C Imbert; T Boraud; C E Gross
Journal:  Synapse       Date:  2000-12-01       Impact factor: 2.562

2.  p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.

Authors:  Wenzhen Duan; Xiaoxiang Zhu; Bruce Ladenheim; Qian-sheng Yu; Zhihong Guo; Jon Oyler; Roy G Cutler; Jean Lud Cadet; Nigel H Greig; Mark P Mattson
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

Review 3.  The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.

Authors:  S Przedborski; V Jackson-Lewis; A B Naini; M Jakowec; G Petzinger; R Miller; M Akram
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

4.  Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.

Authors:  S Pennathur; V Jackson-Lewis; S Przedborski; J W Heinecke
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

5.  Detection of poly(ADP-ribose) polymerase activation in oxidatively stressed cells and tissues using biotinylated NAD substrate.

Authors:  Edina Bakondi; Péter Bai; Eva Szabó E; János Hunyadi; Pál Gergely; Csaba Szabó; László Virág
Journal:  J Histochem Cytochem       Date:  2002-01       Impact factor: 2.479

6.  Enhanced mitochondrial DNA repair and cellular survival after oxidative stress by targeting the human 8-oxoguanine glycosylase repair enzyme to mitochondria.

Authors:  A W Dobson; Y Xu; M R Kelley; S P LeDoux; G L Wilson
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

7.  Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity.

Authors:  Mana Mirjany; Lap Ho; Giulio Maria Pasinetti
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

8.  Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.

Authors:  Guangyu Gu; Patricio E Reyes; Gregory T Golden; Randall L Woltjer; Christine Hulette; Thomas J Montine; Jing Zhang
Journal:  J Neuropathol Exp Neurol       Date:  2002-07       Impact factor: 3.685

9.  Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

Authors:  S Przedborski; V Jackson-Lewis; R Yokoyama; T Shibata; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 10.  DNA single-strand break repair and spinocerebellar ataxia.

Authors:  Keith W Caldecott
Journal:  Cell       Date:  2003-01-10       Impact factor: 41.582

View more
  26 in total

1.  Activation of ataxia telangiectasia muted under experimental models and human Parkinson's disease.

Authors:  Antoni Camins; Javier G Pizarro; Daniel Alvira; Javier Gutierrez-Cuesta; Aurelio Vazquez de la Torre; Jaume Folch; Francesc X Sureda; Ester Verdaguer; Felix Junyent; Joaquín Jordán; Isidre Ferrer; Mercè Pallàs
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

Review 2.  Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

Authors:  Mohammed Akbar; Musthafa Mohamed Essa; Ghazi Daradkeh; Mohamed A Abdelmegeed; Youngshim Choi; Lubna Mahmood; Byoung-Joon Song
Journal:  Brain Res       Date:  2016-02-13       Impact factor: 3.252

3.  Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  F L'Episcopo; C Tirolo; N Testa; S Caniglia; M C Morale; C Cossetti; P D'Adamo; E Zardini; L Andreoni; A E C Ihekwaba; P A Serra; D Franciotta; G Martino; S Pluchino; B Marchetti
Journal:  Neurobiol Dis       Date:  2010-11-05       Impact factor: 5.996

4.  MPTP's pathway of toxicity indicates central role of transcription factor SP1.

Authors:  Alexandra Maertens; Thomas Luechtefeld; Andre Kleensang; Thomas Hartung
Journal:  Arch Toxicol       Date:  2015-04-08       Impact factor: 5.153

5.  The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors:  Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal:  Neurotox Res       Date:  2011-01-14       Impact factor: 3.911

6.  Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson's model: a promising candidate for the treatment of Parkinson's disease.

Authors:  Wu-Fu Chen; Chiranjib Chakraborty; Chun-Sung Sung; Chien-Wei Feng; Yen-Hsuan Jean; Yen-You Lin; Han-Chun Hung; Tzu-Yi Huang; Shi-Ying Huang; Thung-Ming Su; Ping-Jyun Sung; Jyh-Horng Sheu; Zhi-Hong Wen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-27       Impact factor: 3.000

7.  PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.

Authors:  Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

Review 8.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

9.  Pesticides, microglial NOX2, and Parkinson's disease.

Authors:  Thomas Taetzsch; Michelle L Block
Journal:  J Biochem Mol Toxicol       Date:  2013-01-24       Impact factor: 3.642

10.  Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration?

Authors:  Marie-Francoise Doursout; Michael S Schurdell; Lauren M Young; Uzondu Osuagwu; Diana M Hook; Brian J Poindexter; Mya C Schiess; Diane L M Bick; Roger J Bick
Journal:  J Interferon Cytokine Res       Date:  2013-04-19       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.